Skip to content
Search

Latest Stories

NHS to roll out 'health MOTs' in vaccination sites; NPA hopes it's not a 'one-off scheme'

NHS England has announced that it will roll out 'health MOTs' at pharmacies and other vaccination sites this autumn to save thousands of lives.

Speaking at the NHS Confederation Conference on Wednesday (June 16), NHS chief operating officer Amanda Pritchard set out how the health service will make "every contact count" by offering targeted tests such as blood pressure, heart rhythm and cholesterol checks when people drop in for top-up Covid jabs or flu vaccinations.


Responding to the announcement, Mark Lyonette, chief executive of the National Pharmacy Association, hoped that it wasn't just a "one-off scheme limited to a select few pharmacies".

He said: “We don’t yet have the details, but it makes sense for pharmacies to be part of any new initiatives to monitor heart health and cholesterol, given how accessible they are and their proven track record in preventative care.

“It looks like a chance to identify underlying health problems which may have been missed during the coronavirus lockdown, and highlights the important role pharmacies will have in the nation’s post-pandemic reset.

“We hope it’s not a one-off scheme limited to a select few pharmacies, but something that can be scaled to turbo-charge access to cardiac support through community pharmacy.

“Given the magnificent contribution of pharmacies throughout the coronavirus pandemic, it’s natural that they should be seen as a solution in other areas of prevention and public health too.”

Across the country, pharmacists have been offering on-the-spot high-street heart checks to identify patients at risk of cardiovascular disease and stroke as part of an ongoing pilot – providing clinical and lifestyle advice and, where appropriate, referring patients on to treatment.

Claire Anderson, chair of RPS England, said: “This is a welcome recognition of how pharmacists will be central to delivering the NHS Long-Term Plan.

“Pharmacists are often visited by people who do not see their GP, so health MOTs are a great way for pharmacists to use their expertise to discover undiagnosed illnesses.

“As the NHS looks to recovery, we’d want to see additional services commissioned to make best use of pharmacists’ clinical skills.”

Catching major killers such as strokes and heart attacks at an earlier stage is key to the NHS Long Term Plan’s ambitions of saving thousands of lives each year.

In addition to substantial commitments to tackle obesity, alcohol and smoking, the plan aims to prevent 150,000 strokes and heart attacks over the next ten years by improving the treatment of high-risk conditions, such as hypertension (high blood pressure), high cholesterol and atrial fibrillation.

With one stroke prevented and 37 people with irregular heart rates diagnosed for every 5,000 people offered heart checks at vaccination centres, it is estimated that more than 1,000 strokes could be prevented every year if everyone over 65 was offered an annual heart rhythm check.

Dr Leyla Hannbeck, chief executive at the Association of Independent Multiple Pharmacies, said: “We welcome these pilots/case studies run by NHSE where possibilities of providing other prevention and health promotion services alongside Covid-19 vaccination are being tested out.

"Community pharmacy teams across the country, not just in vaccination sites, are ideally placed to deliver health MOTs but this needs to be commissioned and supported appropriately to allow pharmacy teams to have the relevant resource and workforce to deliver additional services.”

At the conference, Pritchard said: “The NHS is not just a sickness service but a health service which is why we want to make every contact count, using every opportunity to keep people well rather than just seeking to make them better.

“We want to offer a fully integrated care system, where we can reach out to people in the communities they live in – not just diagnosing and treating conditions, but working in partnership with the public and intervening before advanced disease occurs, keeping people healthy and well.

“The hugely successful NHS vaccine programme has given us the opportunity to make every contact count by going out into peoples’ communities to beat coronavirus while also catching other killer conditions.

“The checks – like the jabs – will be available in convenient locations in local communities including village halls, churches, mosques and local sports centres and prevent people becoming seriously ill.”

More For You

Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
After US and EU, UK approves Bavarian Nordic’s chikungunya vaccine

Bavarian Nordic plans to launch the vaccine in the UK in summer 2025

Getty Images

Chikungunya vaccine Vimkunya approved for use in the UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Vimkunya, a vaccine developed by Bavarian Nordic A/S to prevent chikungunya disease in people aged 12 years and older.

The UK approval follows earlier approvals by the U.S. Food and Drug Administration (FDA) and the European Commission in February 2025, making this the third regulatory green light for the vaccine.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less
Many patients report inaccuracies or missing details in their NHS medical records

Inaccurate information can result in serious harm or even death, warns Healthwatch England.

Image Credit: Getty Images

1 in 4 adults have spotted errors in their NHS medical records, survey finds

Healthwatch England has raised the alarm over the risks posed by inaccurate medical records as research reveals widespread errors in NHS patient information.

Commissioned by Healthwatch England and conducted by BMG Research, the survey polled a representative sample of 1,800 adults in England between 24 and 27 March 2025.

Keep ReadingShow less
Lib Dems condemn rising unsolved crimes, say shoplifting and burglary ‘effectively decriminalised’

Leicestershire police recorded the lowest charge rate for shoplifting in the country.

Gettyimages

Shoplifting and burglary ‘effectively decriminalised’, warn Lib Dems as unsolved crimes soar

The Liberal Democrats have raised alarm over what they describe as the “decriminalisation” of burglary and shoplifting, as new data reveals that the vast majority of such offences across Britain are going unsolved.

Figures revealed by the House of Commons Library research, commissioned by the party, showed that only 5.25 per cent of shoplifting offences in London last year led to a suspect being charged.

Keep ReadingShow less